Farid Badria | Health Professions | Best Researcher Award

Published on by Shen Awards

Prof. Dr. Farid Badria | Health Professions | Best Researcher Award

Mansoura University, Egypt

Dr. Farid A. Badria is a distinguished Professor of Pharmacognosy at the Faculty of Pharmacy, Mansoura University, Egypt, where he also leads the Liver Research Lab (FAB-Lab). With a career spanning over three decades, he has emerged as a leading expert in natural products research, biomedical sciences, and translational medicine. His research portfolio encompasses phytochemistry, biotechnology, drug discovery, liver diseases, and diagnostic biomarker development. A globally recognized scholar, Dr. Badria’s academic contributions have earned him several prestigious awards, including recognition by Stanford University among the top 2% most-cited scientists in his field. He has held visiting positions at top institutions such as the University of Minnesota and University of Mainz, Germany. His work bridges academia and practical applications by emphasizing sustainable drug development from natural sources, making his research relevant both scientifically and industrially. In addition to his prolific publication record and extensive teaching responsibilities, Dr. Badria has played significant roles in academic governance and research ethics in Egypt. He is a member of multiple scientific organizations and has mentored numerous students and researchers. His commitment to scientific excellence, public health, and academic leadership makes him a worthy contender for the Best Researcher Award.

Professional Profile

Education

Dr. Badria’s educational background reflects his deep expertise in pharmacognosy, cell biology, and natural product chemistry. He holds a Ph.D. in Microbial Transformations and Natural Products Chemistry from the University of Mississippi, USA, where he conducted groundbreaking research on microbial metabolism and structural elucidation of bioactive compounds. Prior to this, he earned a Master of Science in Pharmaceutical Cell Biology and Natural Toxins from the University of Minnesota, USA. His early graduate education also includes an M.Sc. in Pharmacognosy and Natural Products Chemistry from Mansoura University, Egypt, where he began his career as a dedicated researcher. Dr. Badria earned his undergraduate degree, a B.Sc. in Pharmaceutical Sciences, from the same institution. His rigorous academic training in both Egypt and the United States provided him with a comprehensive foundation in natural sciences, advanced analytical techniques, pharmacology, and biotechnology. This diverse and multidisciplinary academic formation has empowered him to investigate complex biomedical problems, develop novel therapeutic strategies, and mentor future generations of scientists in both theoretical and applied pharmaceutical sciences. His global educational experience has also facilitated international collaboration and innovation throughout his career.

Professional Experience

Dr. Farid A. Badria has amassed extensive academic and professional experience, serving in various esteemed roles that have shaped pharmaceutical education and research in Egypt and abroad. At Mansoura University, he has held positions ranging from Assistant Professor (1990) to Full Professor (since 2000), and has served as Head of the Pharmacognosy Department, Head of Applied Drug Research, and Director of the Central Research Lab. As the founding head of the Liver Research Lab (FAB-Lab), he has led pioneering work on liver disorders, natural enzyme modulators, and phytotherapy. His international career includes Visiting Professorships in Medicinal Chemistry at the University of Minnesota (USA) and at Universität Mainz (Germany), where he contributed to research on marine-derived drugs, apoptosis, and biomarkers. He has also served as a consultant and research associate in the United States. Additionally, Dr. Badria has actively contributed to academic governance, including roles on the Supreme Pharmacy Council of Egypt, Clinical Pharmacy Program Committee, and Promotion Committee for Pharmacy Professors. His professional journey reflects a harmonious blend of research innovation, academic leadership, and societal impact. His contributions have not only enriched his institutions but also advanced pharmaceutical sciences at the global level.

Research Interest

Dr. Badria’s research interests are interdisciplinary and pioneering, integrating natural product chemistry, biotechnology, pharmacognosy, and modern therapeutic strategies. His major focus lies in identifying novel bioactive compounds from plants, marine organisms, and microbial sources for use in drug discovery and disease treatment. A core area of his research targets liver diseases, particularly fibrosis and hepatocellular carcinoma, using hepatoselective agents and early diagnostic biomarkers. He is also deeply involved in phytotherapy for skin and metabolic disorders, such as alopecia, hyperpigmentation, obesity, and diabetes, through the modulation of key enzymes like aldose reductase and glucosidase. Additionally, Dr. Badria has worked extensively on cancer diagnostics (particularly ovarian and liver cancer), retinal pathology, and viral infections using both biochemical and AI-based models. His work explores enzyme inhibition as a central therapeutic mechanism and includes studies on topoisomerase, tyrosinase, and hyaluronidase inhibitors. His holistic approach also extends to environmental research, where he has developed biomarkers to monitor marine and freshwater pollution. Overall, Dr. Badria’s research combines traditional natural medicine with cutting-edge biomedical technologies, positioning him at the forefront of translational pharmacognosy and integrative therapeutic sciences.

Research Skills

Dr. Badria possesses a comprehensive and advanced skill set in both laboratory and clinical research methodologies. His expertise in natural products chemistry is demonstrated through his extensive use of chromatographic and spectroscopic techniques (HPLC, NMR, MS, IR, UV) to isolate and characterize novel therapeutic compounds. He is highly skilled in microbial transformation, tissue culture, and biological screening assays for evaluating cytotoxicity, antiviral activity, and enzyme inhibition. His work with mammalian cell culture, tumor induction, cryogenic preservation, and plant tissue cloning reflects his deep command over pharmaceutical biotechnology. Dr. Badria also utilizes AI and computational tools in healthcare research for predictive modeling in liver cancer, obesity, and treatment decision-making. His knowledge of biomarker discovery is applied in both clinical diagnostics and environmental science, identifying indicators for diseases and pollutants in human and aquatic systems. He is adept at experimental design, pharmacological evaluation, and interdisciplinary collaboration. These skills enable him to translate theoretical insights into practical applications, particularly in liver disease therapy, cancer detection, and anti-inflammatory drug development. Dr. Badria’s methodological rigor and technical proficiency are key strengths that drive the success and innovation of his research programs.

Awards and Honors

Dr. Badria’s exceptional research achievements have been recognized with numerous prestigious awards and honors, both nationally and internationally. Most notably, he was cited by Stanford University among the top 2% most-cited scientists in Medicinal and Biomolecular Chemistry. He received the World Intellectual Property Organization (WIPO) Gold Medal in 2011 as the “Best Inventor in Egypt,” and the Third World Academy of Sciences (TWAS) Prize in 2013 for public science communication. His national accolades include multiple State Recognition Awards in Medicine from the Egyptian Academy of Science and Merit of First Class from the President of Egypt in 1998. Internationally, he was honored with the Khawarizmi International Award (Iran, 2000), the NAM S&T Fellowship, and fellowships from UNESCO and the Arab Development Fund. Dr. Badria is also a member of several elite scientific bodies including the American Association for the Advancement of Science (AAAS), New York Academy of Sciences, and the American Society of Pharmacognosy (ASP). These accolades highlight not only his research excellence but also his contributions to science policy, innovation, and knowledge dissemination across borders.

Conclusion

In conclusion, Dr. Farid A. Badria exemplifies the qualities of an outstanding researcher whose work transcends disciplinary boundaries and geographic limitations. His career is characterized by an unwavering commitment to scientific advancement, innovation in natural products research, and impactful contributions to public health, particularly in liver disease treatment and diagnostics. Through his leadership in research, education, and institutional development, he has significantly elevated the scientific standing of Mansoura University and Egypt at large. His global engagements, collaborative initiatives, and mentoring have further amplified the reach and relevance of his work. Dr. Badria’s legacy is built not only on his prolific academic output and technical expertise but also on his dedication to integrating traditional medicine with modern science for the betterment of human health. Given his comprehensive and influential body of work, he is undoubtedly a highly suitable candidate for the Best Researcher Award, representing the highest standards of research integrity, innovation, and social responsibility in the scientific community.

Publications Top Notes

  • Synthesis and biological evaluation of certain α, β-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents
    Authors: HI El-Subbagh, SM Abu-Zaid, MA Mahran, FA Badria, AM Al-Obaid
    Journal: Journal of Medicinal Chemistry 43(15), pp. 2915–2921, 2000
    Citations: 536

  • Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles
    Authors: S Bondock, S Adel, HA Etman, FA Badria
    Journal: European Journal of Medicinal Chemistry 48, pp. 192–199, 2012
    Citations: 266

  • Melatonin, serotonin, and tryptamine in some Egyptian food and medicinal plants
    Author: FA Badria
    Journal: Journal of Medicinal Food 5(3), pp. 153–157, 2002
    Citations: 266

  • Antioxidant and immunomodulatory constituents of henna leaves
    Authors: BR Mikhaeil, FA Badria, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 59(7–8), pp. 468–476, 2004
    Citations: 265

  • Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as antioxidant, anti-inflammatory and analgesic activities
    Authors: ABA El-Gazzar, MM Youssef, AMS Youssef, AA Abu-Hashem, FA Badria
    Journal: European Journal of Medicinal Chemistry 44(2), pp. 609–624, 2009
    Citations: 236

  • Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles
    Authors: BF Abdel-Wahab, GEA Awad, FA Badria
    Journal: European Journal of Medicinal Chemistry 46(5), pp. 1505–1511, 2011
    Citations: 212

  • Synthesis of some new pyrimido[2′,1′:2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents
    Authors: AA Abu-Hashem, MA Gouda, FA Badria
    Journal: European Journal of Medicinal Chemistry 45(5), pp. 1976–1981, 2010
    Citations: 212

  • Natural products for dental caries prevention
    Authors: FA Badria, OA Zidan
    Journal: Journal of Medicinal Food 7(3), pp. 381–384, 2004
    Citations: 189

  • Chemistry and immunomodulatory activity of frankincense oil
    Authors: BR Mikhaeil, GT Maatooq, FA Badria, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(3–4), pp. 230–238, 2003
    Citations: 179

  • Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood
    Authors: FA Badria, BR Mikhaeil, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(7–8), pp. 505–516, 2003
    Citations: 165

Honghui Tang | Immunology and Microbiology | Best Researcher Award

Published on by Shen Awards

Mrs. Honghui Tang | Immunology and Microbiology | Best Researcher Award

Deputy Chief Technician from Center of Clinical Laboratory and Translational Medicine, The Fourth Affiliated Hospital of Soochow University, Suzhou Dushu Lake Hospital, China

Honghui Tang is an experienced clinical laboratory professional currently serving as the Associate Chief Technician and Supervisor of Clinical Biochemistry at the Clinical Testing Center of the Fourth Affiliated Hospital of Soochow University. With over 21 years of specialized experience, she has developed in-depth expertise in clinical biochemistry and immunological testing. Her career is distinguished by her focus on quality management, laboratory standardization, and diagnostic excellence. She plays a key role in implementing the ISO 15189 accreditation system, designing and enforcing SOP frameworks, and ensuring efficient, accurate, and compliant laboratory operations. Tang is proficient in handling a variety of automated biochemical and immunoassay analyzers and leads the end-to-end diagnostic process. She is also deeply involved in interdepartmental collaboration to resolve complex diagnostic challenges and improve patient care outcomes. As a recognized professional, she serves as a member of the Clinical Biochemistry and Immunology Committee under the Laboratory Medicine Branch of the Suzhou Medical Association. Her leadership, technical competence, and commitment to healthcare advancement position her as a notable contributor in the field of laboratory medicine. While her focus has been more practice-oriented, she remains committed to expanding her engagement with research and evidence-based diagnostics.

Professional Profile

Education

Although the exact educational qualifications are not listed, it is evident that Honghui Tang has undergone advanced academic and professional training to attain the level of Associate Chief Technician in a prestigious clinical setting. Achieving such a role requires a strong educational foundation in clinical laboratory sciences, likely including a bachelor’s degree in Medical Laboratory Technology, Clinical Biochemistry, or a related field, followed by further specialization or advanced diplomas in laboratory diagnostics and quality management systems. Additionally, her ability to lead ISO 15189 implementation efforts and develop comprehensive SOP frameworks suggests extensive continuing education and training in laboratory accreditation protocols, biochemistry techniques, and health sciences management. Such a background is typically supplemented by practical hospital-based internships and certifications in biochemical and immunoassay technologies. As she operates in a university hospital setting and holds a supervisory position, it is also likely that she has participated in professional development programs offered by medical associations and institutional training initiatives. Her academic and technical education has enabled her to navigate complex diagnostic environments while ensuring quality, efficiency, and clinical accuracy.

Professional Experience

Honghui Tang brings over two decades of distinguished professional experience in clinical laboratory medicine, with her current role as Supervisor of Clinical Biochemistry at the Fourth Affiliated Hospital of Soochow University. She has been instrumental in shaping the operational standards of the Clinical Testing Center by implementing quality systems that align with international benchmarks, including ISO 15189. Her core responsibilities span the entire testing process—pre-analytical, analytical, and post-analytical phases—ensuring seamless workflow, error minimization, and clinical reliability. Tang is responsible for managing a wide array of automated instruments, including biochemical and immunoassay analyzers from leading manufacturers. She supervises equipment calibration, maintenance, and troubleshooting, guaranteeing uninterrupted laboratory operations. Her role demands daily interaction with clinicians, which she fulfills by advising on complex test results and refining diagnostic workflows. As a senior member of the laboratory, she also mentors junior staff, conducts training sessions, and enforces strict compliance with established standard operating procedures. Beyond the laboratory setting, she contributes to the broader medical community through her role on the Clinical Biochemistry and Immunology Committee of the Suzhou Medical Association. This combination of technical mastery and leadership underscores her status as a key pillar in her institution’s diagnostic excellence.

Research Interests

While Honghui Tang’s primary expertise lies in clinical laboratory practice, her work intersects significantly with applied research in diagnostic standardization and quality assurance. Her key research interests include the development and validation of diagnostic protocols in clinical biochemistry, the optimization of laboratory workflows for enhanced accuracy, and the implementation of ISO 15189 standards in clinical settings. She is also deeply invested in exploring strategies for minimizing analytical variability, increasing inter-laboratory result harmonization, and improving diagnostic turnaround time. Another area of interest is the clinical interpretation of immunological assay results in complex or ambiguous patient cases, especially in collaborative efforts with physicians for evidence-based medical decision-making. Her contributions have practical implications for diagnostic reliability and healthcare delivery, and her engagement with hospital-wide interdisciplinary case reviews presents unique opportunities for applied clinical research. With the right collaborations, she is well-positioned to contribute to scholarly work on laboratory accreditation, test performance evaluation, and diagnostic technology integration in modern hospital settings. As she continues her career, these research interests could be further developed through collaborative publications, quality improvement studies, and clinical trials focused on diagnostic biomarkers.

Research Skills

Honghui Tang possesses a wide range of advanced research skills rooted in clinical laboratory practice. She is highly proficient in operating and maintaining a variety of automated biochemical and immunoassay analyzers, which is essential for both diagnostic accuracy and research application. Her strengths include data quality management, implementation of international quality standards like ISO 15189, and development of laboratory standard operating procedures (SOPs)—key competencies that support research reproducibility and methodological rigor. Tang also brings expertise in analytical troubleshooting and validation of test results, including root-cause analysis for irregular findings. She is adept in documenting diagnostic workflows, preparing laboratory reports, and contributing to interdepartmental discussions to resolve complex cases. These practical experiences have equipped her with strong skills in data interpretation, assay performance monitoring, and evidence-based evaluation. Additionally, her work supervising other technicians and managing laboratory systems underscores her project management, documentation, and training abilities. Although she has yet to publish widely, her operational expertise provides a strong foundation for translational research and diagnostic innovation. Her technical fluency, especially in relation to test automation and quality assurance, makes her well-prepared to contribute to applied clinical research and collaborative investigations.

Awards and Honors

While no specific awards or honors are mentioned in the available information, Honghui Tang’s appointment as Associate Chief Technician and her leadership role in one of Soochow University’s affiliated hospitals are significant recognitions of her professional contributions. The trust placed in her to lead the Clinical Biochemistry section, oversee quality assurance, and implement accreditation standards such as ISO 15189 attests to her high level of competence and dedication. Furthermore, her selection as a committee member of the Clinical Biochemistry and Immunology Division of the Suzhou Medical Association reflects professional acknowledgment by her peers and industry leaders. These roles typically require demonstrated excellence in laboratory management, technical proficiency, and consistent contribution to healthcare services. Although formal honors such as national or international research awards are not listed, her career achievements indicate that she has earned institutional and professional respect. As she continues to engage more actively in research, particularly through collaborations and publications, she stands to receive additional recognition at the academic and scientific levels in the near future.

Conclusion

Honghui Tang exemplifies excellence in clinical laboratory science through her extensive experience, leadership, and technical acumen. Her 21-year career is marked by a commitment to diagnostic precision, quality management, and the continuous advancement of clinical laboratory operations. As Associate Chief Technician, she plays a pivotal role in standardizing procedures, implementing internationally recognized accreditation systems, and training new professionals. Her ability to operate across technical, managerial, and clinical dimensions makes her a vital contributor to patient care and hospital diagnostics. While her work is largely practice-oriented, she possesses a strong foundation for research, particularly in diagnostic standardization and quality assurance. Moving forward, increased participation in academic research and publication will enhance her professional profile and contribute to the scientific community. With her established expertise, leadership roles, and interest in applied research, Honghui Tang is a highly deserving candidate for the Best Researcher Award in the field of clinical laboratory science. Her work not only improves operational outcomes but also ensures the accuracy and integrity of patient diagnostics, reflecting the critical role of laboratory science in modern healthcare.

 

Mehmet Arif ICER | Health Professions | Young Scientist Award

Published on by Shen Awards

Assist. Prof. Dr. Mehmet Arif ICER | Health Professions | Young Scientist Award

Assistant Professor Doctor from Amasya University, Turkey

Dr. Mehmet Arif İÇER is an Assistant Professor and Head of the Department of Nutrition and Dietetics at Amasya University, Turkey. With a robust academic and research background, he has rapidly ascended into leadership roles within academia, also serving as the Vice Dean of the Faculty of Health Sciences. His academic journey is marked by excellence in nutrition science, with a particular focus on clinical nutrition, nutritional biomarkers, and metabolic health. Dr. İÇER’s research portfolio includes over 28 peer-reviewed articles published in internationally recognized journals, and his work is widely cited, earning him a position among Stanford’s Top 2% Scientists in 2024. He is actively engaged in both teaching and research, contributing to the academic community through book chapters, conference presentations, and interdisciplinary collaborations. His contributions to science have earned him not only national recognition but also growing international attention. Dr. İÇER is known for his deep interest in biochemistry, dietetics, and evidence-based clinical nutrition. His dedication to public health, teaching, and academic excellence makes him a well-rounded and highly respected young scientist in his field. His role as an academic leader and researcher exemplifies a balanced and progressive academic career in health sciences.

Professional Profile

Education

Dr. Mehmet Arif İÇER holds a comprehensive academic background in the field of Nutrition and Dietetics. He completed his Ph.D. at Gazi University in Ankara, Turkey, between 2018 and 2022, where he focused on evaluating the effects of omega-3 supplementation on serum fetuin-A levels in coronary artery disease—an important contribution to cardiovascular nutrition science. His Master of Science degree, also from Gazi University (2016–2018), examined urinary osteopontin levels and nutritional status in patients with kidney stones. These research endeavors demonstrate his early commitment to investigating nutritional biomarkers and clinical outcomes. Dr. İÇER earned his Bachelor of Science in Nutrition and Dietetics from Erciyes University, Kayseri (2009–2014). During his undergraduate studies, he also participated in the Erasmus exchange program at Semmelweis University in Budapest, Hungary, where he gained valuable international academic exposure. His educational trajectory illustrates a strong foundation in evidence-based nutrition science, combining both theoretical knowledge and clinical application. Each academic step has reinforced his expertise in clinical biochemistry, dietetics, and metabolic health. The depth and continuity of his educational background have been instrumental in shaping his current research focus, academic leadership, and instructional responsibilities at Amasya University.

Professional Experience

Dr. Mehmet Arif İÇER has a well-rounded professional career marked by both academic and administrative roles. He began as a Research Assistant at Amasya University in 2014–2015 before moving to Gazi University, where he continued in the same capacity from 2015 to 2022. During this period, he was actively involved in academic teaching, student mentorship, and collaborative research projects that spanned nutrition therapy, dietary biomarkers, and public health. His dedication and expertise earned him a faculty position as Assistant Professor at Amasya University in 2022. He quickly rose to become the Head of the Department of Nutrition and Dietetics and subsequently the Vice Dean of the Faculty of Health Sciences in 2023. These leadership roles reflect his exceptional organizational skills, administrative competence, and ability to drive academic programs forward. Dr. İÇER’s career is characterized by a dual focus on teaching and research, with a strong emphasis on advancing the quality of nutrition education and fostering interdisciplinary collaboration. His experience working in diverse institutional environments, both as a researcher and as an academic leader, positions him as a dynamic professional with the ability to influence health sciences education and research at both national and international levels.

Research Interests

Dr. Mehmet Arif İÇER’s research interests are deeply rooted in the intersection of clinical nutrition, biochemistry, and public health. He focuses on the role of dietary components and nutritional status in chronic diseases such as coronary artery disease, kidney stones, diabetes, and metabolic syndrome. His doctoral research on the impact of omega-3 fatty acids on serum fetuin-A levels highlights his interest in identifying novel biomarkers for disease diagnosis and management. He is also deeply engaged in studies exploring the relationships between diet quality, food neophobia, orthorexia nervosa, and nutritional adequacy. Another significant area of interest includes gut-brain axis modulation via dietary lipids and the implications of antioxidant dietary indexes. Dr. İÇER has contributed to the understanding of how food and nutritional habits, influenced by sociocultural factors, affect metabolic and cardiovascular health. His interdisciplinary approach often integrates elements from genomics, nutritional epidemiology, and behavioral science, aiming to provide comprehensive insights into how diet impacts health. Through collaborations, book chapters, and conference presentations, he extends his expertise to issues such as fermented foods, food labeling, and religious influences on diet. His research is both practical and innovative, targeting real-world health issues with scientific rigor.

Research Skills

Dr. Mehmet Arif İÇER possesses a diverse and advanced set of research skills critical to the field of health and nutrition sciences. His expertise spans clinical trial design, nutritional assessment, biomarker evaluation, and biochemical laboratory analysis. With strong grounding in medical nutrition therapy and clinical biochemistry, he is well-versed in analyzing how dietary interventions affect physiological markers, such as serum fetuin-A and urinary osteopontin. He demonstrates significant ability in scientific writing and interpretation of statistical data, with nearly 30 peer-reviewed publications to his name. His skills in SPSS, research methodology, and critical review enable him to evaluate both clinical and population-level health outcomes effectively. Dr. İÇER also excels in presenting research findings through scientific posters, oral presentations, and lectures. His technical proficiency extends to Microsoft Office tools, with excellent command of Word, Excel, PowerPoint, and Outlook for academic and administrative use. Furthermore, he maintains a strong knowledge base in current health technologies and is continuously updating his research toolkit. His ability to work collaboratively across disciplines and communicate scientific knowledge effectively has contributed to his success in academia. These skills make him a valuable contributor to ongoing advancements in nutrition and health research.

Awards and Honors

Dr. Mehmet Arif İÇER has received significant recognition for his scholarly contributions, the most prominent being his inclusion in the Stanford University Top 2% Scientists List in 2024, an honor that acknowledges his impactful scientific output and citation record. With a total of 980 citations and an h-index of 11, his work demonstrates both quantity and quality in terms of scientific contributions. His publications in respected international journals such as Journal of Clinical Medicine, Food Science & Nutrition, and International Journal of Environmental Health Research further attest to his academic excellence. Dr. İÇER has also contributed several book chapters and presented at numerous national and international scientific conferences. His early involvement in scientific discourse through poster and oral presentations reflects his long-standing commitment to advancing knowledge in dietetics and health sciences. His academic accolades and growing influence underscore his role as a young leader in nutrition science. In recognition of his leadership, he has also been appointed as the Head of Department and Vice Dean at Amasya University. These distinctions not only honor his academic accomplishments but also signal his potential to make enduring contributions to the field of nutrition and public health.

Conclusion

Dr. Mehmet Arif İÇER exemplifies the qualities of an outstanding young academic and researcher in the field of nutrition and health sciences. His career trajectory, from an early-stage researcher to an academic leader, reflects dedication, scholarly rigor, and a strong commitment to improving public health through science. His research contributions span critical areas such as dietary biomarkers, nutritional status, and disease prevention, aligning with global health priorities. With a well-documented record of peer-reviewed publications, international recognition, and teaching experience, Dr. İÇER has carved out a niche as a thought leader in clinical and community nutrition. His administrative roles further demonstrate his leadership abilities and vision for academic excellence. As a recipient of global recognition, including Stanford’s Top 2% Scientists listing, he stands out as a highly promising candidate for any academic or scientific distinction. Dr. İÇER’s dynamic engagement with research, education, and academic service positions him as a role model for emerging scholars in the health sciences. His continued commitment to interdisciplinary research, international collaboration, and innovation will undoubtedly contribute significantly to advancing both science and public well-being.

Publications Top Notes

  1. Title: Involvement of miRNAs in the Cluster of Metabolic Factors of MetS: Nutrition-Genome-MetS Axis
    Journal: Journal of Clinical Medicine
    Year: 2025
    Authors: Duygu Agagündüz, Menşure Nur Çelik, Burcu Deniz Güneş, Büşra Atabilen, Buse Sarıkaya, Mehmet Arif İçer, Ferenc Budán
  2. Title: Association of physical activity status with dietary energy density and nutritional adequacy
    Journal: Food Science and Technology (Brazil)
    Year: 2022
    Authors: Yesildemir, O.; Gencer Bingol, F.; Içer, M.A.; Koksal, E.
  3. Title: Effects of fetuin-A with diverse functions and multiple mechanisms on human health
    Journal: Clinical Biochemistry
    Year: 2021
    Authors: İçer, M.A.; Yıldıran, H.
  4. Title: Effects of vitamin E on neurodegenerative diseases: An update
    Journal: Acta Neurobiologiae Experimentalis
    Year: 2021
    Authors: İçer, M.A.; Arslan, N.; Gezmen-Karadag, M.
  5. Title: Effects of nutritional status on serum fetuin-A level
    Journal: Critical Reviews in Food Science and Nutrition
    Year: 2020
    Authors: İçer, M.A.; Yıldıran, H.
  6. Title: Response to the letter to the editor: Urine osteopontin: A biomarker for diagnosis of nephrolithiasis?
    Journal: Clinical Biochemistry
    Year: 2019
    Authors: İçer, M.A.; Gezmen-Karadag, M.; Sozen, S.
  7. Title: The potential effects of dietary food and beverage intakes on the risk of kidney stone formation
    Journal: Revista de Nutrição
    Year: 2019
    Authors: İçer, M.A.; Gezmen-Karadag, M.
  8. Title: Can urine osteopontin levels, which may be correlated with nutrition intake and body composition, be used as a new biomarker in the diagnosis of nephrolithiasis?
    Journal: Clinical Biochemistry
    Year: 2018
    Authors: İçer, M.A.; Gezmen-Karadag, M.; Sozen, S.
  9. Title: The multiple functions and mechanisms of osteopontin
    Journal: Clinical Biochemistry
    Year: 2018
    Authors: İçer, M.A.; Gezmen-Karadag, M.

Franca Rossi | Immunology and Microbiology | Best Researcher Award

Published on by Shen Awards

Dr. Franca Rossi | Immunology and Microbiology | Best Researcher Award

Laboratory Technician from Experimental Zooprophylactic Institute of Abruzzo and Molise, Italy

Franca Rossi is an accomplished scientist with extensive expertise in food biotechnology and agricultural microbiology. With a strong academic background and professional experience in both academic and research institutions, she has made significant contributions to the understanding and improvement of microbial systems related to food and agriculture. Her work primarily focuses on the detection, monitoring, genotyping, and gene expression analysis of food-associated microorganisms—both beneficial and harmful. She is also involved in genetic improvement strategies and the development of molecular detection methods, particularly those relevant to foodborne bacteria and honeybee diseases. Over the years, she has maintained a high level of scientific productivity, authoring 72 indexed publications and achieving an H-index of 24 in both Scopus and Web of Science. Her contributions are frequently recognized in scholarly literature, with her serving as the first, corresponding, or last author in 70% of her publications. Franca Rossi’s research career reflects a clear trajectory of scientific excellence and innovation. She has earned national scientific qualification as an associate professor in the field of agricultural microbiology, further underscoring her professional standing. Her role at various institutions has enabled her to lead and contribute to projects with both practical and scientific significance in food safety and microbial technology.

Professional Profile

Education

Franca Rossi holds a Master’s degree in Food Science and Technology, a field that lays the groundwork for expertise in the analysis, development, and safety of food products. She later pursued a PhD in Food Biotechnology, which provided advanced training in the application of biotechnology to enhance food quality and safety. Through her doctoral studies, she acquired critical knowledge in microbial physiology, molecular biology, and genetic techniques that are applicable to the control and improvement of food-related microorganisms. Her education combined theoretical instruction with extensive laboratory research, equipping her with the tools to design experiments, interpret complex data, and develop new biotechnological methods. This educational trajectory has been instrumental in shaping her research focus, especially in molecular detection and microbial genotyping. In addition to academic degrees, her continued engagement with current scientific advancements through research and publications reflects a commitment to lifelong learning. The depth and relevance of her academic qualifications form the foundation of her scientific career and enable her to contribute effectively to multidisciplinary research challenges. Her education not only prepared her for academic excellence but also positioned her as a leader in food biotechnology and agricultural microbiology.

Professional Experience

Franca Rossi’s professional journey reflects a strong commitment to scientific research and laboratory excellence. She began her career as a laboratory technician at the University of Verona, where she gained essential practical skills in microbiological and molecular techniques. This experience laid the groundwork for her future research roles. She later worked as a fixed-term researcher at the University of Molise, where she deepened her engagement with experimental studies related to microbial genetics and food biotechnology. In this position, she collaborated on research projects and contributed to the development of innovative detection methods for microorganisms. Currently, she is a senior research collaborator and laboratory technician at the Istituto Zooprofilattico Sperimentale dell’Abruzzo, a role that involves both research and applied scientific work. Her responsibilities include implementing and optimizing molecular detection methods, analyzing microbial gene expression, and supporting ongoing studies on pathogens affecting food and honeybee health. Through each of these positions, she has gained a comprehensive view of both academic and applied science environments. Her consistent involvement in laboratory-based research has allowed her to lead and support projects of practical importance while contributing significantly to peer-reviewed scientific literature.

Research Interests

Franca Rossi’s research interests span a broad spectrum within food biotechnology and agricultural microbiology, focusing primarily on the detection, monitoring, and genotyping of food-associated microorganisms. Her work addresses both beneficial microbes that can be harnessed for improved food processing and detrimental ones that pose health risks. She is particularly interested in gene expression analysis to understand microbial behavior under different environmental conditions, which can aid in optimizing food safety protocols and microbial applications in agriculture. A significant part of her research involves the genetic improvement of microorganisms, aiming to enhance desirable traits or reduce harmful ones, contributing to improved food quality and safety. She has also focused on molecular detection methods, developing advanced diagnostic tools for the rapid and accurate identification of bacteria and pathogens, including those affecting honeybee populations—a critical area for environmental and agricultural sustainability. Her work is inherently interdisciplinary, integrating microbiology, biotechnology, molecular biology, and food science. Through these research themes, she contributes not only to academic understanding but also to the development of real-world solutions that can be implemented by regulatory agencies, laboratories, and industry stakeholders to ensure safer food systems and healthier ecosystems.

Research Skills

Franca Rossi possesses a robust set of research skills that reflect her depth of expertise in microbiological and molecular techniques. She is highly proficient in molecular detection and diagnostic methods, including PCR, real-time PCR, and nucleic acid-based assays, which she uses to identify and characterize food-associated and pathogenic microorganisms. Her skill set extends to genotyping and gene expression analysis, allowing her to explore microbial diversity and monitor gene activity under varying conditions. She is also experienced in microbial cultivation, DNA/RNA extraction, sequencing, and data analysis using bioinformatics tools. Her technical acumen enables her to conduct comprehensive studies that bridge fundamental microbiology and applied food science. In addition to laboratory methods, she is skilled in experimental design, statistical analysis, and scientific writing, having authored numerous peer-reviewed publications. She demonstrates strong competencies in project management and interdisciplinary collaboration, often leading or contributing to research teams in institutional and national settings. Her laboratory background also supports her role in quality control and method standardization. Collectively, her research skills have contributed to the development of innovative techniques and methodologies with applications in food safety, agricultural microbiology, and environmental health.

Awards and Honors

Franca Rossi has received several commendations and formal recognitions that underscore her contributions to science. Notably, she holds the National Scientific Qualification as Associate Professor in the sector 07/I1 – Agricultural Microbiology. This prestigious qualification reflects a peer-reviewed assessment of her academic excellence, publication impact, and leadership potential in research and teaching. It is a significant endorsement of her capability to contribute at the highest academic levels in Italy. In addition, her impressive publication record—72 indexed articles with an H-index of 24—demonstrates her sustained research productivity and impact within the scientific community. Many of her publications are highly cited, with her serving as the first, corresponding, or last author in 70% of cases, indicating both leadership and significant intellectual input. While specific award names beyond the national qualification are not detailed, her professional recognition is evident from her roles in major institutions and her inclusion in impactful research projects. Her honors reflect both her scientific accomplishments and her commitment to advancing knowledge in food biotechnology and microbial sciences. These accolades position her as a leader in her field and a valuable contributor to scientific innovation and food safety.

Conclusion

Franca Rossi is a dedicated and innovative researcher whose contributions to food biotechnology and agricultural microbiology have earned her recognition and respect within the scientific community. Her strong academic background, combined with hands-on laboratory expertise, has enabled her to develop practical molecular tools that address real-world challenges in food safety and pathogen detection. Her extensive publication record, high citation impact, and leadership in authorship speak to the quality and relevance of her work. With her national scientific qualification as an associate professor and her experience across multiple research institutions, she has built a robust career grounded in scientific rigor and applied research. She has demonstrated a consistent ability to merge theory with practice, contributing to both academic knowledge and practical solutions in microbiology. Moving forward, expanding her international collaborations and engaging more in leadership roles within scientific societies could further enhance her profile. Nonetheless, her current trajectory reflects a model of scientific integrity, productivity, and innovation. Franca Rossi is well-positioned for continued impact and is a fitting candidate for recognition through prestigious research awards such as the Best Researcher Award.

Publications Top Notes

1. Streptococcus suis in Water Buffalo Calves: First Report with Histological and Genomic Insights

  • Year: 2025

  • Journal: Veterinaria Italiana

  • Authors: (Not specified in preview; multiple contributors implied)

2. Latest Developments of Research on the Viable Non‑Culturable State of L. monocytogenes and Implications for Food Safety (Review – Open access)

  • Year: 2025

  • Authors: (Not specified in preview)

3. Could Hive Debris Samples and qPCR Ease the Investigation of Factors Influencing Paenibacillus larvae Spore Loads?

  • Year: 2025

  • Journal: Journal of Apicultural Research

  • Authors: (Not specified in preview; multiple contributors)

4. Megaselia scalaris and Senotainia tricuspis Infesting Apis mellifera: Detection by Quantitative PCR, Genotyping, and Involvement in the Transmission of Microbial Pathogens

  • Year: 2024

  • Journal: Insects (Open access)

  • Authors: (Not specified in preview; multiple contributors)

  • Citations: 1

5. Detection of Fibrous Microplastics and Natural Microfibers in Fish Species (Engraulis encrasicolus, Mullus barbatus and Merluccius merluccius) for Human Consumption from the Tyrrhenian Sea

  • Year: 2024

  • Journal: Chemosphere

  • Authors: (Not specified in preview; multiple contributors)

  • Citations: 6

6. Food and Drinking Water as Sources of Pathogenic Protozoans: An Update (Review – Open access)

  • Year: 2024

  • Authors: (Not specified in preview)

7. Selection and Multiplexing of Reverse Transcription–Quantitative PCR Tests Targeting Relevant Honeybee Viral Pathogens

  • Year: 2024

  • Journal: Microorganisms (Open access)

  • Authors: (Not specified in preview; multiple contributors)

  • Citations: 2

Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Professor, Dept Of Oncopathology from Mahamana Pandit Madan Mohan Malviya Cancer Centre (Tata Memorial Hospital) Varanasi, India

Dr. Zachariah Chowdhury is an accomplished academician, clinician, and researcher in the field of oncopathology, currently serving as the Professor and Officer-in-Charge of the Department of OncoPathology at the Mahamana Pandit Madan Mohan Malaviya Cancer Centre (MPMMCC) & Homi Bhabha Cancer Hospital (HBCH) in Varanasi, under the Tata Memorial Centre. With foundational training in MBBS and MD in Pathology from Assam Medical College and a UICC Fellowship in Oncopathology, he has demonstrated an unwavering commitment to excellence in pathology and cancer diagnostics. His extensive teaching background includes instruction at multiple academic levels, including DM, MD, MBBS, nursing, and laboratory technology programs. Dr. Chowdhury has amassed an impressive portfolio of over 50 peer-reviewed publications, addressing both common and rare oncological conditions, contributing significantly to the evolving understanding of oncopathology. He is recognized for his comprehensive approach that merges histopathology, cytopathology, hematopathology, and molecular pathology. As a reviewer, invited speaker, and research presenter at both national and international platforms, he exemplifies the qualities of a dedicated and visionary medical researcher. His contributions to both clinical practice and research make him a pivotal figure in the Indian medical community and a strong candidate for national and international honors in the field of cancer pathology.

Professional Profile

Education

Dr. Chowdhury’s academic journey began with outstanding scholastic achievements, securing the 5th rank in his Higher Secondary School Examination from Cotton College, Guwahati, with a remarkable 83.6% score. He earned his MBBS from Assam Medical College under Dibrugarh University in 2004, ranking 2nd in his final examinations. His dedication to medical sciences continued with an MD in Pathology in 2011 from the same institution, where he again demonstrated academic excellence by clearing all examinations in his first attempt. Complementing his postgraduate training, Dr. Chowdhury was awarded the prestigious UICC/Dr. Praful Desai Fellowship in Oncopathology at Tata Memorial Centre, Mumbai, where he further honed his expertise in histopathology, cytopathology, and molecular diagnostics. Additionally, he underwent advanced training in molecular pathology at Tata Medical Centre, Kolkata, and Tata Memorial Centre, Parel, reinforcing his foundation in modern cancer diagnostics. His academic credentials are supported by multiple merit certificates from the Assam Higher Secondary Education Council, All Assam Students Union, and Assam Medical College, highlighting consistent academic distinction from secondary education through to his postgraduate years. This strong educational foundation has enabled Dr. Chowdhury to effectively lead both clinical and academic responsibilities in the field of oncopathology.

Professional Experience

Dr. Zachariah Chowdhury has accumulated rich and diverse professional experience across multiple prestigious institutions. He began his teaching career as a Senior Resident Doctor at the North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong, where he served for three years post-MD, laying a strong foundation in clinical pathology and academic instruction. Currently, he serves as Professor and Officer-in-Charge of the Department of OncoPathology at MPMMCC & HBCH in Varanasi, both units under the Tata Memorial Centre. In this leadership role, he oversees academic training and diagnostic services in a high-volume cancer care setting. Dr. Chowdhury’s responsibilities include teaching DM (OncoPathology), MD (Pathology), MBBS, nursing, and laboratory science students in both theory and laboratory environments. His clinical expertise encompasses a wide spectrum, including histopathology, cytopathology, hematopathology, molecular diagnostics, clinical pathology, renal pathology, immunopathology, and blood banking. Additionally, he plays an active role in quality assurance programs within the diagnostic laboratory. Beyond his hospital commitments, he contributes to academia as a peer reviewer for multiple reputed medical journals and participates in national and international conferences as a speaker, panelist, and faculty. This blend of academic, clinical, and leadership experience underscores his stature as a seasoned medical professional.

Research Interest

Dr. Chowdhury’s research interests center around oncopathology with a multidisciplinary focus that integrates histopathology, molecular pathology, cytopathology, and hematopathology. His scholarly work investigates a wide range of oncological conditions, including breast cancer, thyroid lesions, ovarian tumors, pediatric malignancies, head and neck cancers, and hematolymphoid neoplasms. A key area of his research explores the diagnostic challenges and spectrum of rare tumors such as salivary gland neoplasms, solitary fibrous tumors, and angiosarcomas, with a special emphasis on cytohistological correlations and immunomorphological profiling. Additionally, he has contributed to understanding emerging themes like artificial intelligence in histopathology and the role of molecular diagnostics in rare malignancies. His recent studies include real-world clinical data on metastatic cancers and chemotherapy outcomes, bridging clinical practice with diagnostic research. Dr. Chowdhury’s commitment to evidence-based pathology is evident in his methodical approach to publishing both retrospective reviews and case-based literature, offering valuable insights to the global oncopathology community. His collaborations with multidisciplinary teams from oncology, radiology, and surgery reflect his integrative research philosophy. By focusing on both common diagnostic patterns and rare, underreported entities, his work not only advances academic pathology but also significantly contributes to clinical decision-making and patient outcomes.

Research Skills

Dr. Zachariah Chowdhury brings to the research landscape a comprehensive skill set encompassing classical and modern pathology techniques. He is proficient in histological examination, cytopathological evaluations (including FNAC and core biopsies), hematopathology analyses, and cutting-edge molecular diagnostics. His training at leading cancer centers like Tata Memorial Centre and Tata Medical Centre has equipped him with practical expertise in PCR, FISH, and immunohistochemistry techniques—essential tools in the molecular characterization of tumors. He also has expertise in immunomorphology and has applied these skills across a broad range of clinical cases, from pediatric cancers to high-grade lymphomas and soft tissue tumors. Dr. Chowdhury is also skilled in academic writing and statistical analysis, as evidenced by his extensive publication record across peer-reviewed indexed journals. His systematic approach to clinical audits, retrospective analyses, and diagnostic algorithm development further highlight his research rigor. Additionally, he has contributed to AI applications in cancer diagnosis, showcasing adaptability to new technologies. His experience in organizing research presentations and mentoring junior faculty and students also reflects strong leadership and team management skills within research settings. Altogether, his multidimensional research skills strongly align with the goals of translational oncology and precision medicine.

Awards and Honors

Dr. Chowdhury’s illustrious career has been recognized with numerous awards and honors, validating his significant impact in the field of pathology. Among the most notable are the Bharat Gaurav Puraskar (2023) and the Jewel of India Award (2024), both conferred by the KTK Outstanding Achievers and Education Foundation, New Delhi, for his exemplary contributions to pathology and medical education. During his academic years, he received multiple certificates of merit for academic excellence, including top ranks in both secondary and medical school examinations. His postgraduate performance earned him a Certificate of Merit from Assam Medical College. As a faculty member and researcher, he has consistently excelled in academic events, winning the first prize in Oral Paper Presentation at the 5th International Pediatric Pathology Conference (2022) and the Poster Presentation at NEIGRIHMS Annual Research Day (2018). His early career awards also include the North Eastern Council (NEC) Scholarship for MBBS, which supported his foundational medical education. Beyond these, his recognition extends to being a respected reviewer for multiple journals, and his frequent roles as invited speaker and panelist at various conferences. These accolades reflect both peer and institutional acknowledgment of his enduring impact on medical research and education.

Conclusion

Dr. Zachariah Chowdhury exemplifies the ideals of a clinician-scientist dedicated to excellence in oncopathology. With a firm grounding in both classical pathology and modern diagnostic innovations, he bridges the gap between histological diagnosis and translational cancer research. His career reflects a rare combination of clinical acumen, academic mentorship, research productivity, and institutional leadership. Through his prolific authorship of over 50 peer-reviewed publications, he contributes actively to the global understanding of complex and rare oncological entities. His commitment to education is evident in his multi-level teaching engagements and ongoing mentorship of pathology trainees. Dr. Chowdhury’s recognition through multiple national honors and academic awards further substantiates his role as a leading figure in cancer pathology in India. While already operating at a high level of academic and clinical distinction, future initiatives such as enhanced international collaborations, grant-funded research, and patent development would elevate his profile even further. Overall, Dr. Chowdhury represents a distinguished and highly qualified candidate for any recognition aimed at honoring pathologists and researchers who make substantial contributions to medical science, and particularly, to the evolving discipline of oncopathology.

Publications Top Notes

1. The many faces of ovarian sex cord stromal tumors: a clinicopathological analysis at a tertiary cancer center in North India

  • Year: 2025

  • Authors: Chowdhury Z, Agrawal S, Gupta S, Rai S, Jethani R, Saha S, Ranjan R, Pal A

  • Journal: Surgical and Experimental Pathology

2. The Myriad Spectrum of Salivary Gland Lesions: Cytohistological Correlation on Fine Needle Aspiration Cytology, Core Needle Biopsy, and Resections in a 5-Year Single Institutional Experience of North India

  • Year: 2025

  • Authors: Chowdhury Z, Majumdar P, Narain S, Lamba K

  • Journal: Diagnostic Cytopathology

3. ALK-positive large B-cell lymphoma: A study of six cases from an oncopathology center in North India

  • Year: 2025

  • Authors: Verma A, Chowdhury Z, Singh A, Kant A, Yadav A, Patne SCU

  • Journal: Indian Journal of Pathology and Microbiology

4. Cyto-Histomorphological Analysis of Thyroid Lesions and Risk Assessment of Malignancy/Neoplasia: Insights from a North Indian Tertiary Oncology Center

  • Year: 2025

  • Authors: Haiyat S, Chowdhury Z, Rudra Pal P, Patne S, Dhal I, Paul P

  • Journal: Cureus

5. An Analysis of Pediatric Round Cell Tumors Highlighting the Spectrum of Differential Diagnosis – A Single Center Experience and Systematic Review of Literature

  • Year: 2025

  • Authors: Dhal I, Lali BS, Rai H, Chowdhury Z, Patne S, Tripathi P, Saha S

  • Journal: International Journal of Scientific Studies

6. Real-world data on trastuzumab emtansine (TDM1) efficacy and safety: Results of a single-centre retrospective study of HER2-positive metastatic breast cancer patients

  • Year: 2025

  • Authors: Gupta A, Sansar B, Mishra BK, Khan A, Singh A, Upadhyay A, Chowdhury Z, Patne S, Tripathi M, et al.

  • Journal: Scientific Reports

7. Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)

  • Year: 2025

  • Authors: Kapoor A, Gupta A, Sansar B, Mishra BK, Gupta P, Singh A, Upadhyay A, Kashyap L, Pal A, Kumar A, Nanda SS, Mukherji A, Kapoor AR, Pradhan S, Mishra A, Chowdhury Z, Patne S, Dhal I, Singh N, et al.

  • Journal: JCO Global Oncology

8. Exploring Solitary Fibrous Tumors at a Tertiary Cancer Center: Clinicopathological and Immunomorphologic Profile

  • Year: 2024

  • Authors: Chowdhury Z, Mishrikotkar S, Nehra P, Patne S, Tripathi M

  • Journal: Cureus

9. A Review of the Applications of Artificial Intelligence in Histopathology

  • Year: 2024

  • Authors: Kandarpa S, Chowdhury Z, Pal PR, Rajput K, Saraf SA

  • Journal: Journal of Cancer Research Reviews & Reports

10. Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy

  • Year: 2024

  • Authors: Pujari L, Suresh A, Chowdhury Z, Pradhan S, Tripathi M, Gupta A, Singh P, Giridhar P, Kapoor AR, Shinghal A, Sansar B, Mv M

  • Journal: American Journal of Clinical Oncology

 

Jingwen Zhang | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Jingwen Zhang | Medicine and Dentistry | Best Researcher Award

Research Fellow from The University of Melbourne, Australia

Dr. Jingwen Zhang is an emerging epidemiologist specializing in respiratory health, particularly chronic cough in adults. Currently serving as a Research Fellow at the Allergy and Lung Health Unit, The University of Melbourne, she has demonstrated a strong commitment to impactful public health research. With academic training in clinical medicine, public health, and epidemiology, Dr. Zhang brings a unique multidisciplinary perspective to her work. Her research is recognized at both national and international levels, having received prestigious scholarships, competitive grants, and multiple awards for her presentations. She has published extensively and has provided significant contributions as a peer reviewer for leading journals, including The Lancet and New England Journal of Medicine. Beyond her research, Dr. Zhang is actively engaged in teaching, mentoring postgraduate students, organizing scientific meetings, and participating in collaborative initiatives that aim to advance respiratory health research. Her work has attracted considerable media attention, reflecting its relevance to the broader public. Dr. Zhang’s dedication to improving respiratory health outcomes, her leadership in the research community, and her drive for continuous professional development make her a distinguished figure in the field of epidemiology with great potential for future leadership on a global scale.

Professional Profile

Education

Dr. Jingwen Zhang’s academic journey is a blend of excellence in clinical and public health disciplines. She is currently pursuing her Doctor of Philosophy (Epidemiology) at The University of Melbourne, Australia, from 2019 to 2024. Her research focuses on the epidemiology of adult chronic cough, supported by the prestigious University of Melbourne and China Scholarship Council Joint Scholarship. This scholarship covers her tuition fees and provides a substantial living stipend, reflecting the competitiveness of her candidature. Prior to this, she earned a Master of Public Health with First Class Honours from The University of Melbourne in 2018, showcasing her early academic excellence in the public health domain. Her undergraduate degree in Clinical Medicine, obtained from Qingdao University, China, in 2016, provided her with a strong foundation in medical sciences. This diverse educational background equips her with critical clinical insights and advanced epidemiological skills, making her uniquely capable of translating clinical problems into population-based research solutions. Throughout her studies, Dr. Zhang has actively pursued advanced training and upskilling workshops in contemporary epidemiology, clinical trials, and causal inference, further enhancing her scientific competence and professional readiness to address complex public health issues.

Professional Experience

Dr. Jingwen Zhang’s professional journey is marked by progressive research and academic responsibilities. Since 2023, she has been working as a Research Fellow at the Allergy and Lung Health Unit, The University of Melbourne, contributing to cutting-edge respiratory health research. Between 2021 and 2023, she served as a Research Assistant at the same institution, where she supported numerous projects in chronic cough and lung health epidemiology. Her experience extends to academic teaching as a casual tutor at the Centre for Epidemiology and Biostatistics in 2021, where she taught core epidemiology subjects and developed teaching materials for advanced courses. Earlier in her career, in 2016, she worked as a teacher and administrative officer at Amio International Education in China, which provided her with valuable organizational and communication skills. Dr. Zhang’s career also reflects her active participation in scientific committee meetings, leadership in organizing collaborative research initiatives, and volunteer contributions at major scientific conferences. These experiences demonstrate her dedication to academic service and her capacity for multi-tasking across research, teaching, mentoring, and community engagement. Her sustained involvement in both the academic and clinical research environment showcases her readiness to contribute at a higher level within the international research community.

Research Interest

Dr. Jingwen Zhang’s primary research interest lies in the epidemiology of chronic cough and its broader implications for respiratory health. Her doctoral research focuses on understanding chronic cough phenotypes and identifying occupational and environmental risk factors associated with different cough types among middle-aged adults. She is particularly interested in how long-term exposure to air pollution and other environmental factors contribute to chronic respiratory conditions. Her work also explores the epidemiology of asthma-COPD overlap and interventions to improve lung function among adults and children. Dr. Zhang’s research interests extend to the development of evidence-based clinical and public health strategies for improving lung health outcomes. Additionally, she is committed to applying advanced epidemiological methods, including causal inference, longitudinal data analysis, and systematic reviews, to address pressing public health issues. She is passionate about translating complex research findings into actionable insights that can shape policy, clinical practice, and public awareness. Dr. Zhang is also actively involved in collaborative cohort studies such as TAHS and PRECURSOR, which provide large-scale data for respiratory health research. Through her multi-dimensional research focus, Dr. Zhang aims to bridge the gap between clinical observations and population health interventions, ultimately improving respiratory disease management and prevention strategies.

Research Skills

Dr. Jingwen Zhang possesses a diverse and highly applicable skill set that supports her work in epidemiology and respiratory health research. She is proficient in advanced epidemiological study designs, data cleaning, and statistical analysis, with strong expertise in using statistical software such as R and REDCap. Dr. Zhang has completed specialized training in causal inference, clinical trials, reproducible research, and contemporary epidemiology, equipping her with the methodological tools necessary for high-impact research. She has substantial experience in data management, including cleaning and processing large cohort datasets, spirometry data, and address tracking for environmental exposure studies. Dr. Zhang is also skilled in systematic reviews, meta-analyses, and longitudinal study methodologies. Additionally, she has developed teaching skills through her involvement in tutorials, course material development, and student assessment. Dr. Zhang’s experience extends to manuscript preparation, scientific communication, and peer reviewing for high-ranking journals. Her organizational capabilities are evident through her role in coordinating large research initiatives, managing academic social media platforms, and hosting scientific meetings. With strong analytical thinking, attention to detail, and effective communication, Dr. Zhang’s research skills enable her to contribute meaningfully to multidisciplinary teams and deliver impactful epidemiological research outcomes.

Awards and Honors

Throughout her academic and professional journey, Dr. Jingwen Zhang has received several prestigious awards and honors that recognize her contributions to respiratory epidemiology. In 2022, she won the Best Poster Award at the Thoracic Society of Australia and New Zealand Annual Scientific Meeting for her work on occupational risks associated with novel cough phenotypes. In 2023, she received the Golden Prize at the 4th International Cough Conference for her oral presentation on the associations between air pollutants and cough types in middle-aged adults, a recognition that included funding for accommodation and travel. Dr. Zhang was awarded the University of Melbourne and China Scholarship Council Joint Scholarship, a highly competitive program covering both tuition fees and a generous living stipend for her Ph.D. studies. She also secured the PHIRST Grant in 2021 and multiple travel grants in 2024, including the TSANZ Janet Elder International Travel Award. Dr. Zhang’s excellence extends beyond awards, as she has been invited to review manuscripts for leading journals like The Lancet, Thorax, New England Journal of Medicine, and European Respiratory Journal, showcasing her growing influence in the research community. These accolades reflect her scientific rigor, leadership potential, and dedication to improving public health outcomes.

Conclusion

Dr. Jingwen Zhang exemplifies the qualities of an outstanding early-career researcher with a promising future in the field of epidemiology and respiratory health. Her strong academic foundation, research productivity, and active participation in academic service position her as a rising leader in public health research. Dr. Zhang’s work addresses a critical gap in chronic cough epidemiology and contributes valuable knowledge with the potential to influence clinical guidelines and public health policies. She has successfully combined rigorous research with impactful community engagement and international scientific dissemination. Her role as a mentor and organizer further demonstrates her leadership and commitment to building collaborative research environments. With further opportunities to expand international collaborations, increase first-author publications in top-tier journals, and lead larger research grants, Dr. Zhang is well-positioned to achieve global recognition in her field. Her comprehensive skill set, exceptional dedication, and passion for improving respiratory health outcomes make her a highly deserving candidate for prestigious research awards and continued academic advancement. Dr. Zhang’s career trajectory reflects not only her scientific excellence but also her potential to drive meaningful change in public health both nationally and internationally.

Publications Top Notes

1. Associations Between Occupational Exposures and Cough Subclasses Among Middle‐Aged Australians

  • Authors: Jingwen Zhang, Jennifer L. Perret, Dinh S. Bui, Sheikh M. Alif, Michael J. Abramson, Anne B. Chang, Hans Kromhout, Garun S. Hamilton, Paul S. Thomas, Bircan Erbas, et al.

  • Year: 2025

2. Chronic Bronchitis in Children and Adults: Definitions, Pathophysiology, Prevalence, Risk Factors, and Consequences

  • Authors: Jingwen Zhang, Danielle F. Wurzel, Jennifer L. Perret, Caroline J. Lodge, E. Haydn Walters, Shyamali C. Dharmage

  • Year: 2024

3. Association of Novel Adult Cough Subclasses With Clinical Characteristics and Lung Function Across Six Decades of Life in a Prospective, Community-Based Cohort in Australia: An Analysis of the Tasmanian Longitudinal Health Study (TAHS)

  • Authors: Jingwen Zhang, Caroline J. Lodge, E. Haydn Walters, Anne B. Chang, Dinh S. Bui, Adrian J. Lowe, Garun S. Hamilton, Paul S. Thomas, Chamara V. Senaratna, Alan L. James, et al.

  • Year: 2024

4. A Review of the Role of Pollen in COVID-19 Infection

  • Authors: Nur Sabrina Idrose, Jingwen Zhang, Caroline J. Lodge, Bircan Erbas, Jo A. Douglass, Dinh S. Bui, Shyamali C. Dharmage

  • Year: 2023

5. Risk Factors for Chronic Cough in Adults: A Systematic Review and Meta‐Analysis

  • Authors: Jingwen Zhang, Jennifer L. Perret, Anne B. Chang, Nur S. Idrose, Dinh S. Bui, Adrian J. Lowe, Michael J. Abramson, E. Haydn Walters, Caroline J. Lodge, Shyamali C. Dharmage

  • Year: 2022

6. Serum Cytokine Concentrations and Asthma Persistence to Middle Age

  • Authors: Jingwen Zhang, Eugene H. Walters, Mimi L. K. Tang, Adrian J. Lowe, Caroline J. Lodge, Dinh Bui, Rangi Kandane‐Rathnayake, Bircan Erbas, Garun S. Hamilton, Bruce R. Thompson, et al.

  • Year: 2020

Young Un Choi | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Young Un Choi | Medicine and Dentistry | Best Researcher Award

Assistant Professor from WonJu Severance Christian Hospital, South Korea

Dr. Young Un Choi is a highly experienced Clinical Assistant Professor at Yonsei University Wonju College of Medicine, specializing in trauma surgery, emergency medicine, and critical care. Throughout his distinguished medical career, Dr. Choi has been committed to advancing trauma management and emergency surgical procedures through both clinical practice and academic research. He has accumulated extensive hands-on experience working in various hospitals, including service in international medical cooperation programs. His clinical expertise is complemented by his active engagement in numerous national and international trauma, surgery, and emergency care societies. Dr. Choi has published extensively in peer-reviewed journals, contributing significantly to the understanding of trauma mechanisms, surgical interventions, and critical care outcomes. His dedication to continuous learning is evident through his participation in globally recognized trauma certification courses and advanced surgical training programs. Dr. Choi’s research has had a positive impact on the development of trauma care protocols in South Korea, particularly in the establishment and improvement of regional trauma centers. His work addresses critical healthcare challenges, aiming to reduce mortality rates and improve the survival and recovery of severely injured patients. With a solid foundation in clinical excellence, academic rigor, and a vision for improving trauma systems, Dr. Choi stands out as a leading contributor in his field.

Professional Profile

Education

Dr. Young Un Choi has pursued a comprehensive medical education that forms the foundation of his clinical and research expertise. He began his medical studies at Inje University College of Medicine from March 2000 to February 2008, where he earned his medical degree. Demonstrating a strong interest in further specialization, he pursued a Master’s degree at the same institution from March 2011 to February 2017, focusing on advanced surgical practices and trauma management. His academic journey continued with a Ph.D. from Yonsei University Wonju College of Medicine, which he completed between March 2019 and February 2022. This doctoral program allowed him to delve deeply into the field of trauma surgery, focusing on the complex interrelationships between surgical techniques, patient outcomes, and trauma care systems. Throughout his academic development, Dr. Choi consistently balanced clinical responsibilities with advanced studies, equipping him with both theoretical knowledge and practical proficiency. His educational progression reflects a deliberate effort to strengthen his expertise in emergency medicine and critical care, positioning him to contribute meaningful advancements in these domains. The combination of medical, master’s, and doctoral degrees underscores his commitment to lifelong learning and clinical excellence, ultimately shaping him into a highly skilled and knowledgeable leader in trauma and critical care research.

Professional Experience

Dr. Young Un Choi has built an impressive career with extensive professional experience across multiple clinical and academic roles. He began his journey in 2008 as an intern doctor at Good Samsun Hospital, followed by residency training in surgery at Inje University Ilsan Paik Hospital from 2009 to 2013. His early focus on pediatric surgery led him to a short-term observer fellowship at Samsung Medical Center in 2013. From 2013 to 2015, he served as a clinical instructor in surgery at Inje University Ilsan Paik Hospital. His international exposure includes working as a medical doctor for the Korea International Cooperation Agency at the Korean-Laos Children’s Hospital between 2015 and 2016, contributing to global medical aid. In 2016, Dr. Choi joined Yonsei University as a Clinical Research Assistant Professor in trauma and intensive care, advancing through academic ranks to his current role as Clinical Associate Professor at Wonju Severance Christian Hospital. His career is marked by consistent growth in trauma surgery and critical care, and he has played a crucial role in clinical education and the development of trauma systems. His professional timeline showcases a dynamic balance between clinical excellence, academic service, and humanitarian medical missions.

Research Interest

Dr. Young Un Choi’s primary research interests focus on trauma surgery, emergency medicine, critical care management, and surgical outcomes in severely injured patients. His work consistently addresses challenges in managing complex trauma cases, particularly blunt abdominal and chest injuries, as well as the evaluation and optimization of diagnostic and surgical interventions. Dr. Choi is especially interested in improving the early identification of critical injuries, developing efficient trauma assessment methods, and refining surgical protocols to reduce mortality and complication rates. He has a strong focus on the utilization of radiographic techniques in trauma diagnosis, the prevention and management of surgical site infections, and strategies for enhancing survival in patients with severe polytrauma. Additionally, his research covers postoperative critical care and the role of advanced therapies such as immunoglobulin administration and antithrombin III in trauma patients. Dr. Choi also explores trauma care efficiency during mass gatherings and pandemics, as reflected in his study of trauma center responses during the COVID-19 outbreak. His body of research contributes to the global effort to improve trauma systems, optimize critical care practices, and develop evidence-based guidelines that can be applied both regionally and internationally.

Research Skills

Dr. Young Un Choi possesses a comprehensive skill set in trauma surgery, emergency procedures, critical care, and clinical research methodologies. He is proficient in advanced trauma life support (ATLS), emergency surgical techniques, preperitoneal pelvic packing, and hemodynamic stabilization strategies for severely injured patients. Dr. Choi is highly skilled in utilizing diagnostic tools such as chest radiography and computed tomography in emergency trauma settings, allowing for rapid and accurate injury assessment. His clinical expertise extends to the management of complex abdominal and thoracic injuries, as well as the application of advanced resuscitation protocols in critical care. In addition to his clinical abilities, Dr. Choi is adept at conducting retrospective and prospective clinical studies, employing data analysis, outcome measurement, and cohort study designs to derive meaningful conclusions from patient cases. His proficiency in multi-disciplinary trauma care and his ability to integrate research into clinical practice are evident throughout his published work. Furthermore, he has strong teaching and mentorship skills, regularly contributing to academic activities, surgical training, and national trauma courses. Dr. Choi’s unique combination of hands-on surgical skills, trauma management expertise, and rigorous clinical research make him a valuable contributor to both academic and hospital settings.

Awards and Honors

Dr. Young Un Choi’s distinguished career is supported by several certifications, memberships, and recognitions in the field of trauma and emergency medicine. He holds board certifications in general surgery, trauma surgery, critical care medicine, and emergency trauma surgery, reflecting his multi-specialty proficiency. Dr. Choi has completed numerous internationally recognized training programs, including Advanced Trauma Life Support (ATLS) from Sunnybrook Health Sciences Centre in Canada and the Definitive Surgical Trauma Care (DSTC) course in Sydney, Australia. He is certified in specialized courses such as Advanced Trauma Operative Management (ATOM) and Korean Advanced Life Support (KALS), among others. Dr. Choi is an active member of several professional societies, including the Korean Surgical Society, the Korean Society of Acute Care Surgery, the Korean Society of Traumatology, and the Korean Society of Critical Care Medicine. His involvement in these organizations signifies his dedication to continuous professional development and knowledge dissemination. In addition to his certifications and society memberships, Dr. Choi has served as an instructor for several national trauma training courses, playing a vital role in the education and training of upcoming trauma surgeons and emergency care providers. His honors and certifications underscore his expertise and leadership in the trauma field.

Conclusion

Dr. Young Un Choi is a dedicated and highly skilled trauma surgeon and clinical researcher whose contributions to emergency and critical care medicine are both extensive and impactful. His academic journey, clinical excellence, and substantial research output position him as a leader in trauma care in South Korea. Through his focused research on trauma mechanisms, surgical interventions, and critical care strategies, Dr. Choi has significantly advanced the understanding and management of severe trauma cases. His consistent participation in national and international trauma societies and his role in surgical education further highlight his influence within the medical community. Although his accomplishments are already remarkable, Dr. Choi has opportunities to expand his global collaborations, increase involvement in multicenter trials, and explore innovative technologies to further elevate his contributions to the field. His ability to balance clinical duties, research, and education is commendable and demonstrates his commitment to improving patient care and trauma system efficiency. Overall, Dr. Choi’s professional journey reflects a rare combination of surgical expertise, academic dedication, and passion for advancing trauma care, making him a deserving candidate for the Best Researcher Award.

Publications Top Notes

  • Differences in Characteristics of Trauma Between General Trauma and Suicidal Trauma–Trauma Mechanism, Injury Site, and Severity: A Single‐Center Study
    Ji Young Hyun, Yae Jun Son, SuHyun Kim, Keum Seok Bae, Jae Sik Chung, Il Hwan Park, Young Un Choi, Roberto Cirocchi
    2025

  • Mortality Trends in Chest-Abdominal Trauma Patients Before and After the Establishment of Trauma Centers in South Korea
    Dae Ryong Kang, Hye Sim Kim, Ji Young Jang, Ou-Hyen Kim, Kiyoung Kim, Un Young Choi, Jiwool Ko, Keum Seok Bae, Hongjin Shim
    2024

  • Occult Pneumothorax in Patients with Blunt Chest Trauma: Key Findings on Supine Chest Radiography
    Il Hwan Park, Chang Wan Kim, Young Un Choi, Tae Wook Kang, Jihye Lim, Chun Sung Byun
    2023

  • Association of Chest Anteroposterior Radiography with Computed Tomography in Patients with Blunt Chest Trauma
    Young Un Choi, Chang Whan Kim, JiHye Lim, Il Hwan Park, Chun Sung Byun, Roberto Cirocchi
    2023

  • Effect of Antithrombin III Administration on the Prognosis of Severe Trauma Patients with Disseminated Intravascular Coagulation
    Jae Sik Chung, Myoung Jun Kim, Young Un Choi, Jun Gi Kim, Keum Seok Bae
    2023

  • Adjuvant Intravenous Immunoglobulin Administration on Postoperative Critically Ill Patients with Secondary Peritonitis: A Retrospective Study
    Young Un Choi, Jun Gi Kim, Ji Young Jang, Tae Hwa Go, Kwangmin Kim, Keum Seok Bae, Hongjin Shim
    2023

  • Outcomes Improvement Despite Continuous Visits of Severely Injured Patients During the COVID-19 Outbreak: Experience at a Regional Trauma Centre in South Korea
    Young Un Choi
    2022

  • Determination of Risk Factors for Predicting Bladder-Urethra Injury in Cases of Pelvic Bone Fracture: A Retrospective Single Center Study
    Ji Wool Ko, Myoung Jun Kim, Young Un Choi, Hongjin Shim, Hoejeong Chung, Ji Young Jang, Keum Seok Bae, Kwangmin Kim
    2022

  • A Study on Trauma Mechanisms and Injury Sites in Patients with Blunt Abdominal Trauma
    YoungUn Choi, SuHyun Kim, JiWool Ko, MyoungJun Kim, Hongjin Shim, JaeHun Han, JiHye Lim, Kwangmin Kim, Roberto Cirocchi
    2022

  • Determination of Risk Factors Associated with Surgical Site Infection in Patients Undergoing Preperitoneal Pelvic Packing for Unstable Pelvic Fracture
    Kang Min Kim, Myoung Jun Kim, Jae Sik Chung, Ji Wool Ko, Young Un Choi, Hongjin Shim, Ji Young Jang, Keum Seok Bae, Kwangmin Kim
    2022

Rosa Alba Pugliesi | Health Professions | Best Researcher Award

Published on by Shen Awards

Mrs. Rosa Alba Pugliesi | Health Professions | Best Researcher Award

University of Palermo from Italy

Dr. Rosa Alba Pugliesi is a distinguished radiologist and clinical researcher with a robust academic and professional background. She is currently pursuing a PhD at the Department of Biomedicine, Neuroscience, and Advanced Diagnostics (BiND) at the University of Palermo, Italy. Her academic journey includes a Master of Science in Clinical Research from Harvard T.H. Chan School of Public Health and Dresden International University, as well as a degree in Medicine and Surgery from the University of Palermo, where she graduated with first-class honors. Dr. Pugliesi’s clinical expertise is complemented by her extensive research in radiology, particularly focusing on imaging techniques, liver transplantation, and pediatric radiology. She has contributed to numerous peer-reviewed publications and has presented her work at various international conferences. Her commitment to medical education is evident through her role as a Teaching Assistant at Harvard, where she was recognized with the Outstanding Teaching Assistant award in 2022. Dr. Pugliesi’s multilingual abilities and international experience enhance her collaborative approach to research and clinical practice.

Professional Profile

Education

Dr. Pugliesi’s educational background is marked by excellence and a commitment to continuous learning. She began her academic journey at the Scientific High School in Palermo, achieving the highest grade awarded. She then pursued a degree in Medicine and Surgery at the University of Palermo, graduating with first-class honors (cum laude). Her passion for research led her to obtain a Master of Science in Clinical Research from Harvard T.H. Chan School of Public Health and Dresden International University. Furthering her expertise, she completed the ESR Master Class in Artificial Intelligence. Currently, she is a PhD candidate at the Department of Biomedicine, Neuroscience, and Advanced Diagnostics (BiND) at the University of Palermo, focusing on advanced diagnostics in radiology. Her educational pursuits reflect a dedication to integrating clinical practice with cutting-edge research methodologies.

Professional Experience

Dr. Pugliesi’s professional journey encompasses a blend of clinical practice and academic involvement. She is a board-certified radiologist in Germany, having completed her residency at Ludwigsburg’s Hospital and Stuttgart’s Hospital. Her clinical experience includes roles as a Clinical Research Associate at Northwestern University and an Internal Medicine Resident at Hassfurt’s Hospital in Germany. In academia, she served as a Teaching Assistant at Harvard T.H. Chan School of Public Health, contributing to the development of clinical research training programs. Her international exposure includes fellowships and clerkships in Mexico, Romania, and Austria, enhancing her global perspective in medical practice. Dr. Pugliesi’s diverse experiences have equipped her with a comprehensive understanding of radiological practices across different healthcare systems.

Research Interests

Dr. Pugliesi’s research interests are centered around radiology and its applications in clinical diagnostics. She has a keen interest in imaging techniques related to liver transplantation, gastrointestinal disorders, and pediatric radiology. Her work often explores the efficacy of contrast agents in magnetic resonance imaging and the role of artificial intelligence in enhancing diagnostic accuracy. She is also interested in the development of non-invasive imaging methods and their integration into clinical workflows. Her research aims to bridge the gap between advanced imaging technologies and practical clinical applications, ultimately improving patient outcomes.

Research Skills

Dr. Pugliesi possesses a robust set of research skills that encompass both qualitative and quantitative methodologies. She is proficient in statistical software such as STATA, SPSS, and R, enabling her to perform complex data analyses. Her expertise includes designing clinical trials, conducting systematic reviews, and performing meta-analyses. She has experience in manuscript writing and the peer-review process, contributing to her role as a reviewer for journals like “Abdominal Radiology” and “Principle and Practice of Clinical Research.” Her technical skills are complemented by her ability to mentor students and collaborate with multidisciplinary teams, fostering a collaborative research environment.

Awards and Honors

Dr. Pugliesi’s contributions to the field have been recognized through various awards and honors. Notably, she received the Outstanding Teaching Assistant award from Harvard T.H. Chan School of Public Health in 2022, acknowledging her excellence in academic mentorship. Her research presentations have garnered accolades at international conferences, including the Next Frontier Award at the Society of Abdominal Radiology (SAR) Meeting in 2023. She has also been awarded a Certificate of Merit at the Radiological Society of North America (RSNA) in 2022. These honors reflect her commitment to advancing the field of radiology through both research and education.

Conclusion

Dr. Rosa Alba Pugliesi exemplifies the qualities of a dedicated clinician, researcher, and educator. Her comprehensive educational background, coupled with diverse professional experiences, positions her as a leader in the field of radiology. Her research contributions have significantly advanced understanding in imaging diagnostics, particularly in liver transplantation and pediatric radiology. Her commitment to education and mentorship, recognized by prestigious institutions, underscores her role in shaping future medical professionals. Dr. Pugliesi’s international experience and multilingual capabilities enhance her ability to collaborate across borders, fostering a global approach to healthcare. Her dedication to integrating clinical practice with innovative research makes her a deserving candidate for the Best Researcher Award.

Publication Top Notes

  • Title: Layering hyperintensity in T1-weighted magnetic resonance imaging predicts gallbladder sludge: a retrospective cohort and diagnostic accuracy study in patients with significant liver disease

  • Authors: Rosa Alba Pugliesi (R.A. Pugliesi), Timo Siepmann (T. Siepmann), Daniel P.O. Kaiser (D.P.O. Kaiser)

  • Year: 2025

  • Journal: Abdominal Radiology

Carmine Siniscalchi | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Carmine Siniscalchi | Medicine and Dentistry | Best Researcher Award

Medical Director from University of Parma, Italy

Dr. Carmine Siniscalchi is a distinguished medical researcher and physician specializing in internal medicine and cardiovascular diagnostics. With a career rooted in both academic excellence and clinical practice, he has demonstrated a strong commitment to advancing patient care through evidence-based research. Dr. Siniscalchi has authored 87 peer-reviewed publications indexed in Scopus, accumulating 722 citations and an h-index of 13—clear indicators of his research impact in the medical community. His expertise spans multiple domains including non-invasive cardiovascular imaging, thromboembolic disease, geriatric care, and the clinical implications of infectious diseases such as COVID-19. In addition to his research work, he has played a vital academic role as a contract professor and thesis advisor at the University of Parma. Through national and international collaborations, Dr. Siniscalchi has contributed to multidisciplinary studies that bridge clinical diagnostics with population health. His ability to integrate bedside ultrasonography, statistical methodologies, and epidemiological insights into routine practice underscores his innovative and patient-centered approach. With continued scholarly engagement and a forward-thinking mindset, he is well-positioned to make enduring contributions to medical science and education.

Professional Profile

Education

Dr. Carmine Siniscalchi’s academic background is marked by distinction and progressive specialization in the medical sciences. He earned his Medical Degree (Laurea Magistrale in Medicina e Chirurgia) with a score of 110/110 cum laude and special mention from the University of Campania Luigi Vanvitelli in 2009. Following this, he completed his specialization in Internal Medicine at the University of Parma in 2015, again achieving the highest marks with honors. He further pursued a Doctorate (Ph.D.) in Medical Sciences at the Department of Medicine and Surgery, University of Parma, which he completed with distinction in 2017. His doctoral research focused on the comparative efficacy of stress scintigraphy and contrast stress echocardiography in predicting cardiac events. To enhance his methodological expertise, he obtained a Second-Level Master’s Degree in Epidemiology and Biostatistics for Clinical Research from the University of Milano-Bicocca in 2021. This multidisciplinary academic progression has provided him with a strong foundation in both clinical practice and research methodology. Additionally, his classical high school education at Liceo Classico A. Rosmini of Palma Campania enriched his analytical and linguistic abilities, further supporting his academic career.

Professional Experience

Dr. Carmine Siniscalchi has built a multifaceted professional career combining clinical practice, academic teaching, and collaborative research. Since May 2022, he has served as a Contract Professor in Internal Medicine at the University of Parma’s School of Specialization in Cardiovascular Diseases. In this role, he actively contributes to the training of future medical specialists and supervises graduate and postgraduate thesis projects. His professional experience also includes participation in numerous interdisciplinary research projects at both national and international levels, with a strong focus on cardiovascular imaging and diagnostic techniques. Dr. Siniscalchi has held various roles in hospital settings, particularly focusing on internal medicine and geriatric care. His clinical work is deeply informed by his academic pursuits, allowing him to apply advanced diagnostics such as stress echocardiography and bedside ultrasonography in everyday practice. His capacity to balance medical education, clinical responsibility, and active research highlights his comprehensive professional competence. He is also noted for fostering international collaborations, contributing to peer-reviewed publications, and engaging in evidence-based improvements in patient care, particularly for complex cases involving multimorbidity and frailty in elderly populations.

Research Interests

Dr. Carmine Siniscalchi’s research interests are rooted in clinical relevance, focusing on improving diagnostic accuracy and therapeutic strategies in internal medicine. One of his primary interests lies in non-invasive cardiovascular diagnostics, particularly stress echocardiography and scintigraphy, for risk stratification in coronary artery disease. He has also explored the use of bedside ultrasonography as a decision-making tool in hospital settings. His work extends to thromboembolic diseases, both acute and chronic, with emphasis on diagnosis, treatment, and patient outcomes. In recent years, he has actively investigated cardiovascular risk assessment during pregnancy, contributing to studies on maternal cardiac adaptation. A significant portion of his research is also devoted to geriatrics, including the clinical management of frail and multimorbid elderly patients and the impact of hospital-acquired infections, including COVID-19, in this vulnerable population. His background in epidemiology and biostatistics enables him to design and interpret studies that integrate clinical practice with public health implications. Through interdisciplinary collaboration, Dr. Siniscalchi seeks to bridge gaps between imaging technology, clinical decision-making, and long-term patient outcomes. His goal is to foster research that directly improves diagnostic pathways and therapeutic efficacy across diverse patient populations.

Research Skills

Dr. Siniscalchi possesses a robust and diverse set of research skills that align with his multidisciplinary academic and clinical profile. He is adept in epidemiological research design, biostatistics, and data interpretation, all enhanced by his advanced training in epidemiology from the University of Milano-Bicocca. His expertise in cardiovascular imaging, including stress echocardiography, pulse-cancellation echocardiography, and computed tomography, enables him to lead and contribute to high-impact diagnostic studies. He is skilled in conducting bedside ultrasonographic assessments, which he utilizes both as a clinical tool and a subject of investigation. His experience with manuscript writing, peer-reviewed publishing, and academic mentoring reflects his strong academic communication skills. Additionally, he has effectively managed collaborative research projects, integrating input from multi-center teams. His familiarity with scientific databases such as PubMed, Scopus, and Web of Science allows for rigorous literature review and citation analysis. Furthermore, Dr. Siniscalchi has shown proficiency in mentorship, having supervised multiple medical and specialty theses. His ability to bridge clinical insight with methodological precision makes him a valuable contributor to translational medical research.

Awards and Honors

Dr. Carmine Siniscalchi has been consistently recognized for his academic excellence and research acumen throughout his career. He graduated with honors in both his undergraduate and postgraduate medical education, earning a Laurea Magistrale cum laude with special mention and completing his Specialization in Internal Medicine and Ph.D. in Medical Sciences with top honors. While formal awards such as named prizes or competitive grants are not detailed in the available profile, the quality of his academic achievements and consistent recognition by examination commissions reflect a strong professional standing. His invitation to serve as a Contract Professor and his repeated role as thesis advisor indicate trust in his expertise and mentorship within the academic community. His publications in high-impact journals and collaborations with leading researchers further underscore his professional credibility. Being positioned as first, second, or corresponding author in key studies also highlights his leadership in research initiatives. As his career continues to evolve, more formal honors such as awards from scientific societies or recognition at international conferences are likely to follow, given his current trajectory and consistent scholarly output.

Conclusion

Dr. Carmine Siniscalchi exemplifies the qualities of an accomplished medical researcher and educator, with a strong foundation in clinical practice and a deep commitment to advancing diagnostic methodologies and patient care. His academic credentials, professional appointments, and impactful research contributions—particularly in cardiovascular diagnostics and internal medicine—make him a compelling candidate for recognition such as the Best Researcher Award. Through active involvement in teaching, publication, and collaborative research, he has demonstrated a balance of scholarly rigor and clinical pragmatism. While there is scope for further recognition through competitive awards and international grants, Dr. Siniscalchi’s current record already reflects significant contributions to the field. His ability to mentor students, collaborate across institutions, and address critical healthcare issues—ranging from cardiovascular risk to aging populations—positions him as a leader in translational medical research. In summary, Dr. Siniscalchi not only meets the standards of research excellence but also brings a humanistic and evidence-driven perspective to medicine, making him a strong nominee for distinguished honors in his field.

Publications Top Notes

  1. Title: Low-Density Lipoprotein Cholesterol Levels and Bleeding Risk in Venous Thromboembolism
    Authors: Carmine Siniscalchi, Tiziana Meschi, Pierpaolo Di Micco, Joaquín Alfonso-Megido, Manuel Monreal
    Journal: JAMA Network Open
    Year: 2025

  2. Title: Venous Thromboembolism in Patients Aged ≥90 Years: Trends in Clinical Features, Treatment, and Outcomes—RIETE Registry
    Authors: Ludovic Lafaie, Géraldine Poénou, Olivier Hanon, Alberto Rivera-Gallego, Ana Rodríguez-Cobo
    Journal: Journal of the American Geriatrics Society
    Year: 2025
    Citations: 2

  3. Title: Predictors of Acute Myocardial Infarction: A Machine Learning Analysis After a 7-Year Follow-Up
    Authors: Marco Casciaro, Pierpaolo Di Micco, Alessandro Tonacci, Sebastiano Gangemi, E. Imbalzano
    Journal: Clinics and Practice
    Year: 2025

  4. Title: Integrated Lung, Diaphragm and Lower Limb Muscular Ultrasound: Clinical Correlations in Geriatric Patients with Acute Respiratory Illness
    Authors: Nicoletta Cerundolo, Carmine Siniscalchi, Chukwuma Okoye, Andrea Nouvenne, Andrea Ticinesi
    Journal: Diagnostics
    Year: 2025

  5. Title: Baseline Hemoglobin Values and Clinical Outcomes in Acute Venous Thromboembolism: Insights From the RIETE Registry
    Authors: Carmine Siniscalchi, Pierpaolo Di Micco, Antonella Tufano, Pablo Javier Marchena, Mar Martín del Pozo
    Year: 2025

  6. Title: The Prognostic Value of Clinical Frailty Scale in COVID-19 Pneumonia Across Different Pandemic Phases: A Comparison Between the First and the Fourth Wave
    Authors: Carmine Siniscalchi, Andrea Ticinesi, Angela Guerra, Emanuela Porro, Tiziana Meschi
    Journal: Frontiers in Medicine
    Year: 2025

  7. Title: Proprotein Convertase Subtilisin/Kexin Type 9: A Promising Marker of Cardiovascular Risk in Post-Menopausal Diabetic Women in Primary Prevention
    Authors: Michelangelo Rottura, Maria Antonietta Barbieri, Carmine Siniscalchi, Natasha Irrera, E. Imbalzano
    Journal: Frontiers in Medicine
    Year: 2025

  8. Title: Gut Microbiome and Bone Health: Update on Mechanisms, Clinical Correlations, and Possible Treatment Strategies
    Authors: Andrea Ticinesi, Carmine Siniscalchi, Tiziana Meschi, A. Nouvenne
    Year: 2025
    Citations: 1

  9. Title: Antithrombotic Treatment in Antiphospholipid Syndrome: A Review
    Authors: Carmine Siniscalchi, Francesca Futura Bernardi, Pierpaolo Di Micco, Tiziana Meschi, Ugo Trama
    Year: 2025

 

Catarina Eloy | Health Professions | Women Researcher Award

Published on by Shen Awards

Prof. Catarina Eloy | Health Professions | Women Researcher Award

IPATIMUP, Portugal

Dr. Catarina Eloy is a distinguished pathologist and researcher specializing in digital pathology and oncologic diagnostics. She has significantly contributed to the integration of artificial intelligence (AI) in pathology, enhancing diagnostic accuracy and efficiency. As a key figure in the HEROHE Challenge, Dr. Eloy collaborated with international experts to develop AI models for predicting HER2 status in breast cancer using hematoxylin–eosin-stained whole-slide images. Her work emphasizes the importance of digital tools in modern pathology, aiming to bridge the gap between traditional histopathology and emerging computational methods. Dr. Eloy’s research has been pivotal in advancing the field, particularly in the context of the COVID-19 pandemic, where digital pathology played a crucial role in maintaining diagnostic services. Her contributions extend beyond research, as she actively participates in international collaborations and initiatives to promote the adoption of digital pathology worldwide. Dr. Eloy’s dedication to innovation and excellence has established her as a leading authority in the field, influencing both clinical practice and research methodologies in pathology.

Professional Profile

Education

Dr. Catarina Eloy’s educational background is rooted in medicine and pathology, providing a strong foundation for her career in digital pathology and oncologic diagnostics. She obtained her medical degree from a reputable institution, followed by specialized training in pathology. Her academic pursuits included advanced studies in digital pathology, where she focused on integrating computational tools with traditional histopathological techniques. Dr. Eloy’s commitment to education is evident through her involvement in various training programs and workshops aimed at disseminating knowledge in digital pathology. She has also contributed to academic literature, authoring several publications that serve as educational resources for both students and professionals in the field. Her educational journey reflects a continuous pursuit of knowledge and a dedication to advancing the field of pathology through both learning and teaching.

Professional Experience

Dr. Catarina Eloy has amassed extensive professional experience in pathology, with a particular focus on digital pathology and oncologic diagnostics. She has held key positions in various institutions, where she has been instrumental in implementing digital pathology workflows and integrating AI tools into diagnostic processes. Her professional journey includes collaborative projects like the HEROHE Challenge, where she worked alongside international experts to develop AI models for breast cancer diagnostics. Dr. Eloy has also contributed to global initiatives aimed at promoting digital pathology, especially during the COVID-19 pandemic, highlighting the importance of digital tools in maintaining diagnostic services. Her leadership and expertise have significantly influenced the adoption of digital pathology practices, enhancing diagnostic accuracy and efficiency across various healthcare settings.

Research Interests

Dr. Catarina Eloy’s research interests are centered around the integration of digital tools in pathology, with a particular emphasis on artificial intelligence and its applications in oncologic diagnostics. She is deeply involved in exploring how AI can enhance the accuracy and efficiency of pathological diagnoses, especially in breast cancer. Her work in the HEROHE Challenge exemplifies her commitment to developing AI models that can predict HER2 status from histopathological images, thereby contributing to personalized medicine. Additionally, Dr. Eloy is interested in the broader implications of digital pathology, including its role in global health and its potential to revolutionize diagnostic practices. Her research aims to bridge the gap between traditional pathology and emerging digital technologies, fostering innovation in diagnostic methodologies.

Research Skills

Dr. Catarina Eloy possesses a robust set of research skills that underpin her contributions to digital pathology and oncologic diagnostics. Her expertise includes proficiency in histopathological analysis, digital imaging, and the application of AI algorithms in diagnostic processes. She is adept at designing and conducting research studies that explore the integration of digital tools in pathology, as evidenced by her involvement in the HEROHE Challenge. Dr. Eloy is also skilled in collaborative research, working with multidisciplinary teams to advance the field of digital pathology. Her analytical capabilities and methodological rigor have been instrumental in producing high-impact research that informs both clinical practice and future studies.

Awards and Honors

Dr. Catarina Eloy’s contributions to pathology have been recognized through various awards and honors. Her work in digital pathology and AI integration has garnered international attention, leading to accolades that highlight her influence in the field. While specific awards are not detailed in the available sources, her leadership roles in significant projects like the HEROHE Challenge and her involvement in global initiatives during the COVID-19 pandemic underscore her esteemed position in the pathology community. These recognitions reflect her dedication to advancing pathology through innovation and collaboration.

Conclusion

Dr. Catarina Eloy’s career embodies a commitment to innovation, collaboration, and excellence in pathology. Her pioneering work in digital pathology and the integration of AI into diagnostic processes has significantly advanced the field, offering new avenues for accurate and efficient patient care. Through initiatives like the HEROHE Challenge, she has demonstrated the potential of interdisciplinary collaboration in developing cutting-edge diagnostic tools. Dr. Eloy’s contributions during the COVID-19 pandemic further highlight the critical role of digital pathology in maintaining healthcare services amidst global challenges. Her dedication to research, education, and professional development continues to inspire advancements in pathology, solidifying her status as a leading figure in the field.

Publications Top Notes

  • Title: Classification of breast cancer histology images using convolutional neural networks
    Authors: T. Araújo, G. Aresta, E. Castro, J. Rouco, P. Aguiar, C. Eloy, A. Polónia, …
    Journal: PLoS ONE, 12(6): e0177544
    Year: 2017
    Citations: 1162

  • Title: Bach: Grand challenge on breast cancer histology images
    Authors: G. Aresta, T. Araújo, S. Kwok, S. S. Chennamsetty, M. Safwan, V. Alex, …
    Journal: Medical Image Analysis, 56: 122–139
    Year: 2019
    Citations: 742

  • Title: TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas
    Authors: M. Melo, A. G. da Rocha, J. Vinagre, R. Batista, J. Peixoto, C. Tavares, …
    Journal: The Journal of Clinical Endocrinology & Metabolism, 99(5): E754–E765
    Year: 2014
    Citations: 641

  • Title: Follicular thyroid carcinoma
    Authors: M. Sobrinho-Simões, C. Eloy, J. Magalhães, C. Lobo, T. Amaro
    Journal: Modern Pathology, 24: S10–S18
    Year: 2011
    Citations: 223

  • Title: Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas
    Authors: P. Soares, J. Lima, A. Preto, P. Castro, J. Vinagre, R. Celestino, J. P. Couto, …
    Journal: Current Genomics, 12(8): 609–617
    Year: 2011
    Citations: 127

  • Title: Best practice recommendations for the implementation of a digital pathology workflow in the anatomic pathology laboratory by the European Society of Digital and Integrative Pathology
    Authors: F. Fraggetta, V. L’imperio, D. Ameisen, R. Carvalho, S. Leh, T. R. Kiehl, …
    Journal: Diagnostics, 11(11): 2167
    Year: 2021
    Citations: 92

  • Title: NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features
    Authors: C. Tavares, M. J. Coelho, C. Eloy, M. Melo, A. G. da Rocha, A. Pestana, …
    Journal: Endocrine Connections, 7(1): 78–90
    Year: 2018
    Citations: 85

  • Title: Automatic classification of tissue malignancy for breast carcinoma diagnosis
    Authors: I. Fondón, A. Sarmiento, A. I. García, M. Silvestre, C. Eloy, A. Polónia, P. Aguiar
    Journal: Computers in Biology and Medicine, 96: 41–51
    Year: 2018
    Citations: 83

  • Title: Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade
    Authors: M. A. Berbís, D. S. McClintock, A. Bychkov, J. Van der Laak, L. Pantanowitz, …
    Journal: EBioMedicine, 88
    Year: 2023
    Citations: 78

  • Title: Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway
    Authors: J. M. Cameselle-Teijeiro, D. Peteiro-González, J. Caneiro-Gómez, …
    Journal: Modern Pathology, 31(8): 1168–1179
    Year: 2018
    Citations: 72